Abstract
Purulent bacterial conjunctivitis affects all ages with high frequency in newborns and children. In a subset of 150 children included in a large study having enrolled 1043 patients, our aim was to analyze in children, the efficacy and safety of azithromycin 1.5% eye-drops in the treatment of this disease. This multicenter, randomized, investigator-masked, parallel-group study, included 150 children and adolescents to study safety and compare azithromycin 1.5% eye drops twice daily for 3 days and tobramycin 0.3% 1 drop every 2 hours for 2 days then 4 times daily for 5 days. Out of 150 patients included, 58 had positive cultures and were studied for efficacy. Signs and symptoms were evaluated and cultures obtained at baseline, Days 3 and 9. Primary efficacy variable was the clinical cure (score 0 for bulbar conjunctival injection and purulent discharge) at the test of cure visit (day 9). Both treatments were effective with a clinical and microbiologic cure of more than 80% of children on day 9. Azithromycin therapy provided a greater bacteriologic cure on day 3 than did tobramycin (P < 0.001) and eradicated bacteria that were defined as resistant, using classical antibiogram. No adverse effects were noted on the ocular surface. A...Continue Reading
References
Nov 1, 1992·Drugs·D H PetersD McTavish
Sep 1, 1992·Archives of Ophthalmology·A Gwon
Dec 1, 1987·Antimicrobial Agents and Chemotherapy·J RetsemaR Mason
Dec 1, 1988·Antimicrobial Agents and Chemotherapy·J A JacobsonR B Turner
Apr 1, 1984·The Journal of Pediatrics·F GigliottiJ Lohr
Jan 1, 1981·Current Eye Research·G CagleJ Smith
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·S JaruratanasirikulS Tussanasunthornwong
Aug 1, 1997·Clinical Pediatrics·R D GrossR N Lindsay
Dec 31, 1998·Archives of Ophthalmology·K F TabbaraG Foulds
Aug 14, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A JauchG Gamba
Apr 28, 2001·Drugs·G G ZhanelJ A Karlowsky
Mar 21, 2003·The New England Journal of Medicine·Michael MartinCynthia G Whitney
Jul 26, 2003·The British Journal of Ophthalmology·D G HwangUNKNOWN Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group
Oct 21, 2003·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Steven J LichtensteinUNKNOWN Levofloxacin Bacterial Conjunctivitis Study Group
Aug 17, 2004·Infectious Disease Clinics of North America·Jerry M Zuckerman
Nov 17, 2004·Current Pharmaceutical Design·R Jain, L H Danziger
Apr 20, 2005·Archives of Surgery·Harmik J SoukiasianAlfredo Trento
Sep 29, 2006·The British Journal of Ophthalmology·Isabelle CochereauPierre-Yves Robert
Oct 20, 2006·The British Journal of Ophthalmology·Isabelle CochereauTristan Bourcier
Oct 26, 2007·Statistics in Medicine·G Y Zou, A Donner
Citations
Mar 3, 2011·Current Infectious Disease Reports·Onsiri Thanathanee, Terrence P O'Brien
Mar 17, 2012·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Julie BlavinTristan Bourcier
Jul 14, 2011·Clinical Ophthalmology·Canan Asli Utine
Feb 10, 2012·Drugs·Karly P Garnock-Jones
Feb 15, 2014·The British Journal of Ophthalmology·Dominique Bremond-GignacUNKNOWN AZI Study Group
Jul 18, 2012·Journal of Pediatric Ophthalmology and Strabismus·Melike Balikoglu-YilmazMuhittin Taskapili
Jan 1, 2012·Ophthalmology and Eye Diseases·Dominick L Opitz, Jennifer S Harthan
Jan 1, 2011·Ophthalmology and Eye Diseases·D Bremond-GignacS Milazzo
Sep 14, 2012·The Cochrane Database of Systematic Reviews·Aziz SheikhUlugbek Nurmatov
May 27, 2016·Science China. Life Sciences·Qingfeng LiangAilian Hu
Jun 11, 2019·Korean Journal of Ophthalmology : KJO·Erum ShahidAtya Rehman